Calum Chace's Blog, page 6
December 12, 2022
When will we stop eating animals? With Jacy Anthis
Jacy Reese Anthis is a polymath and rising star in the fields of Effective Altruism (EA) and artificial intelligence (AI). He is a co-founder of the Sentience Institute and the author of the 2018 book “The End of Animal Farming”. EA is the project of identifying the most impactful strategies to help others, and the book grew out of EA research into the best ways to help animals.
When will we stop eating animals?
Jacy Reese Anthis is a polymath and rising star in the fields of Effective Altruism (EA) and artificial intelligence (AI). He is a co-founder of the Sentience Institute and the author of the 2018 book “The End of Animal Farming”. EA is the project of identifying the most impactful strategies to help others, and the book grew out of EA research into the best ways to help animals.
Breaking out of the Simulation. With Roman Yampolskiy
In the 4th century BC, the Greek philosopher Plato theorised that humans do not perceive the world as it really is. All we can see is shadows on a wall. In 2003, the Swedish philosopher Nick Bostrom published a paper which formalised an argument to prove Plato was right. The paper argued that one of the following three statements is true: 1. We will go extinct fairly soon 2.
Breaking out of the Simulation
In the 4th century BC, the Greek philosopher Plato theorised that humans do not perceive the world as it really is. All we can see is shadows on a wall. In 2003, the Swedish philosopher Nick Bostrom published a paper which formalised an argument to prove Plato was right. The paper argued that one of the following three statements is true: 1. We will go extinct fairly soon 2.
How Insilico Medicine uses AI to accelerate drug development
Within the longevity research community, Alex Zhavoronkov is well-known for his relentless focus. He works seven days a week and takes no holidays. The hard work is paying off: In February, Insilico Medicine, the AI drug development company he founded, announced the first phase 1 clinical trials for a wholly AI-developed drug. Following a series of investment rounds in the rest of the year...
November 14, 2022
Taking back control of the Singularity
David Wood’s new book, “The Singularity Principles” is published at an opportune moment. A growing number of well-informed people are saying that the technological singularity – the arrival of superintelligent machines – now appears to be much nearer than they used to think. If it is, then the job of making sure the outcome is positive for humans becomes urgent. Wood and I discussed his book in...
Regenerating the thymus: profile of Greg Fahy
We heard a great deal about T cells during the Covid pandemic. They are crucial to resisting infection, and they are manufactured in your thymus, a small organ behind your breastbone. Unfortunately, the thymus starts to deteriorate when you are young, which is why the elderly were particularly susceptible to Covid. Greg Fahy was already a successful and noted cryobiologist when he embarked on a...
November 6, 2022
Could you – and should you – get paid to do AI safety research?
How close are we to artificial general intelligence (AGI), a machine with all the cognitive ability of an adult human? Surveys of AI researchers indicate that professionals think the most likely timeline is a decade or so either side of the middle of this century. That is not very long, but quite a few well-informed people think it could be even sooner. One such person is Ross Nordby...
Extending health spans by extending telomeres: profile of Liz Parrish
Patient zero Liz Parrish was nervous. She was on a plane to Colombia, where she would undergo an untested gene therapy. She and her colleagues had spent two years developing the therapy and making the preparations, but they could not know how it would work out. It was September 2015, and Parrish had been inspired to take this step because her son, suffering from type 1 diabetes...
Superintelligence may be closer than most people think, says neuroscientist
There is a paradox in artificial intelligence (AI). The technology is already very powerful, and most people agree that it will transform every industry and every aspect of our lives. But deployment of AI in industry seems to be proceeding slower than expected. One explanation for this is that CEOs and CTOs are understandably nervous about deploying systems that are unpredictable.
